Btk inhibitors in atherosclerosis

    Research output: Contribution to journalReview article

    Abstract

    In this issue of Blood, Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.

    Original languageEnglish (US)
    Pages (from-to)2601-2602
    Number of pages2
    JournalBlood
    Volume131
    Issue number24
    DOIs
    StatePublished - Jun 14 2018

    Fingerprint

    Atherosclerotic Plaques
    Platelets
    Platelet Aggregation
    Atherosclerosis
    Blood
    Agglomeration
    Agammaglobulinaemia tyrosine kinase

    ASJC Scopus subject areas

    • Biochemistry
    • Immunology
    • Hematology
    • Cell Biology

    Cite this

    Btk inhibitors in atherosclerosis. / Lindner, Jonathan.

    In: Blood, Vol. 131, No. 24, 14.06.2018, p. 2601-2602.

    Research output: Contribution to journalReview article

    Lindner, Jonathan. / Btk inhibitors in atherosclerosis. In: Blood. 2018 ; Vol. 131, No. 24. pp. 2601-2602.
    @article{316cec06d48f4dfb95645da780e7e2da,
    title = "Btk inhibitors in atherosclerosis",
    abstract = "In this issue of Blood, Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.",
    author = "Jonathan Lindner",
    year = "2018",
    month = "6",
    day = "14",
    doi = "10.1182/blood-2018-04-841916",
    language = "English (US)",
    volume = "131",
    pages = "2601--2602",
    journal = "Blood",
    issn = "0006-4971",
    publisher = "American Society of Hematology",
    number = "24",

    }

    TY - JOUR

    T1 - Btk inhibitors in atherosclerosis

    AU - Lindner, Jonathan

    PY - 2018/6/14

    Y1 - 2018/6/14

    N2 - In this issue of Blood, Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.

    AB - In this issue of Blood, Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.

    UR - http://www.scopus.com/inward/record.url?scp=85048724343&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85048724343&partnerID=8YFLogxK

    U2 - 10.1182/blood-2018-04-841916

    DO - 10.1182/blood-2018-04-841916

    M3 - Review article

    AN - SCOPUS:85048724343

    VL - 131

    SP - 2601

    EP - 2602

    JO - Blood

    JF - Blood

    SN - 0006-4971

    IS - 24

    ER -